RxDoctor Payments Data

Dennis Whatley, MD

Urology · Anderson, SCNPI 1518079839

Payments from drug & device makers

$4,133in general payments, 2019–2025

Across 225 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coloplast$1K
  • Astellas Pharma US Inc$359
  • Johnson & Johnson$342
  • Boston Scientific$219
  • Sumitomo Pharma America, Inc.$210
  • Bayer$173
  • plus $2K from 36 others

What the payments were for

  • Food & beverage$3,99997%
  • Education$1343%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,133 in reported general payments places this provider in the 50th percentile of 196 urology providers in South Carolina.

See all urology providers in South Carolina

Medicare billing

Part B allowed, 2024
$307,636
Medicare patients
717
Services billed
9,256

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XtandiEnzalutamide12$177,149
MyrbetriqMirabegron95$59,842
GemtesaVibegron27$13,759
Solifenacin Succinate135$9,685
Tamsulosin Hcl523$6,640
Alfuzosin Hcl ErAlfuzosin Hcl216$6,340
Finasteride352$4,728
Trospium Chloride29$1,711
Cephalexin124$913
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst52$894
Tolterodine Tartrate ErTolterodine Tartrate15$748
Methenamine Hippurate12$563
Dutasteride18$498
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim90$354
Ampicillin Trihydrate26$345

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncXtandi, Myrbetriq$359$236,991107 claims
Sumitomo Pharma America, Inc.Gemtesa$210$13,75927 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 196 urology providers in South Carolina.

Other urology in Anderson

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →